SHERWOOD CHARLES H 4
4 · Anika Therapeutics, Inc. · Filed Oct 16, 2017
Insider Transaction Report
Form 4
SHERWOOD CHARLES H
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2017-10-12$60.00/sh−1,908$114,480→ 172,797 total - Sale
Common Stock
2017-10-13$60.11/sh−5,216$313,534→ 167,581 total
Footnotes (2)
- [F1]On October 12, 2017, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on February 21, 2017, Dr. Sherwood sold 1,908 shares in a single trade at $60.00.
- [F2]On October 13, 2017, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on February 21, 2017, Dr. Sherwood sold 5,216 shares in multiple trades ranging from $60.00 to $60.17. The price reported above reflects the weighted average sale price. Dr. Sherwood undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected.